Education
About Us
Working with TipRanks
Follow Us
Capricor Therapeutics (CAPR)
NASDAQ:CAPR
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 22.27M | $ 25.18M | $ 2.55M | $ 244.90K |
| Gross Profit | $ 0.00 | $ -27.70M | $ -11.27M | $ -19.27M | $ 244.90K |
| Operating Income | $ -108.14M | $ -42.56M | $ -24.08M | $ -29.70M | $ -20.94M |
| EBITDA | $ -108.14M | $ -41.14M | $ -23.01M | $ -29.16M | $ -20.69M |
| Net Income | $ -105.04M | $ -40.47M | $ -22.29M | $ -29.02M | $ -20.02M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 318.13M | $ 151.52M | $ 39.49M | $ 41.42M | $ 34.89M |
| Total Assets | $ 355.95M | $ 170.48M | $ 58.73M | $ 50.09M | $ 41.33M |
| Total Debt | $ 20.94M | $ 1.45M | $ 2.24M | $ 2.56M | $ 2.87M |
| Net Debt | $ -266.90M | $ -9.84M | $ -12.46M | $ -7.04M | $ -32.01M |
| Total Liabilities | $ 50.16M | $ 25.02M | $ 36.13M | $ 38.31M | $ 9.96M |
| Stockholders' Equity | $ 305.79M | $ 145.46M | $ 22.60M | $ 11.79M | $ 31.37M |
| Cash Flow | |||||
| Free Cash Flow | $ -72.72B | $ -41.53M | $ -27.64M | $ 1.56M | $ -18.01M |
| Operating Cash Flow | $ -69.81B | $ -40.00M | $ -25.60M | $ 4.92M | $ -16.81M |
| Investing Cash Flow | $ 97.48B | $ -116.18M | $ 5.11M | $ -35.07M | $ -1.20M |
| Financing Cash Flow | $ 248.89B | $ 152.77M | $ 25.58M | $ 4.87M | $ 20.23M |